Navigation Links
Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering One's Risk of Infection During Treatment
Date:9/10/2009

LOS ANGELES, Sept. 10 /PRNewswire/ -- Award-winning actresses Edie Falco and Cynthia Nixon appear in a new Stand Up To Cancer(TM) (SU2C) public service campaign to educate cancer patients and their loved ones about the increased risk of infection during cancer treatment and the importance of learning how to manage one's risk.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/amgen/39907/

(Photo: http://www.newscom.com/cgi-bin/prnh/20090910/NY73333 )

Often patients are overwhelmed with medical information once they have been diagnosed with cancer. Many do not fully understand the risk of infection during chemotherapy and the potential impact it has on one's overall treatment success. The campaign's goal is to encourage cancer patients and their caregivers to actively work with their physicians to learn what can be done to lower the risk of infection before starting chemotherapy.

"Learning you have cancer comes as a complete shock and, at first, makes you feel powerless," says Falco, SU2C ambassador and cancer survivor. "You really need to take control early. It is important to work with your team of physicians at the outset to understand how to minimize your risk of infection and stay strong throughout your treatment plan."

"Being told that you have cancer is devastating," adds Nixon, SU2C ambassador and cancer survivor. "But you need to stay empowered. Through this Stand Up To Cancer campaign, we hope to encourage cancer patients and their loved ones to get all the facts, including how you can minimize the risk of infection during treatment."

The public service campaign, "Manage Your Treatment," includes both print and broadcast announcements, and was created by Stand Up to Cancer(TM) with support from Amgen. Starting this fall, the 30- and 60-second broadcast spots will begin airing and the print version of the PSA will appear in major women and lifestyle magazines. The PSA directs people to www.manageyourtreatment.com for more information.

Cancer patients are at higher risk for infection due to a compromised immune system caused by both the cancer itself and, often, by chemotherapy treatment. Neutropenia, a low white blood cell count, is a common and potentially dangerous side effect of chemotherapy. It can lead to a heightened risk of infection that can require hospitalization and be life-threatening. Each year, 60,000 cancer patients are hospitalized for chemotherapy-induced neutropenia. Neutropenia also can disrupt chemotherapy treatment, including both dose delays and dose reductions, which -- for certain types of cancer -- may impede a patient's ability to achieve the best long-term results.

ABOUT STAND UP TO CANCER(TM)

The Stand Up To Cancer initiative was created in 2008 to accelerate groundbreaking cancer research that will get new therapies to patients quickly and save lives. SU2C's goal is to bring together the best and the brightest in the cancer community, encouraging collaboration instead of competition. By galvanizing the entertainment industry, SU2C creates awareness and builds broad public support for this effort. Stand Up To Cancer is a program of the Entertainment Industry Foundation, the 501(c)(3) tax-exempt organization that serves as the collective philanthropy for the television and film businesses. Visit standup2cancer.org.

ABOUT AMGEN

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Amgen is a proud partner with Stand Up to Cancer(TM) as part of the company's ongoing commitment to advances in cancer treatment. Amgen believes this partnership not only provides additional needed funds for cancer research, but also demonstrates that joining forces is essential to fighting and overcoming this disease.

CONTACTS:

Ashleigh Koss: 805-313-6151 (Amgen)

Maurine Slutzky: 213-240-3923 (Stand Up To Cancer)


'/>"/>
SOURCE SU2C/Amgen
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: U.S. Department of Health and Human Services Joins Ad Council and Warner Bros. Pictures to Combat Childhood Overweight and Obesity
2. Video: Home-Spun or Hard Fact?
3. Video: Eat Tastefully Campaign: Diet Coke, Renowned Chef, Pop-Up Kitchen Reveal Secrets to Great Taste, Living Well
4. Video: Swedish Medical Center Adds Two New da Vinci Surgical Systems to Support Robot-Assisted Surgical Team
5. Video: FDA States Consumers Should Continue to Use alli
6. Video: Renowned Health Expert Dra. Aliza Teams Up With Baby Looney Tunes To Promote Healthy, Happy Babies
7. Video: Life Insurance Awareness Month is the Ideal Time for an Insurance Review
8. Video: Physical and Mental Health of U.S. Warfighter Is Focus of Military Health Research Forum
9. Video: Project Runway Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma
10. Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol
11. Video: HHS Launches Best Bones Forever!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, 2017 , ... ... half of all Americans, yet poor sleep is likely not the only cause of ... these undesirable characteristics that make you look older or in poor health are likely ...
(Date:3/23/2017)... ... 23, 2017 , ... Corra Group is now offering exclusively ... Verisys through its FACIS and other services maintains the largest healthcare database ... are delighted to be able to offer these various products to our healthcare ...
(Date:3/23/2017)... McKinney, Texas (PRWEB) , ... March 23, 2017 ... ... Operations Command (USSOCOM) awarded Task Force Dagger Foundation the US Special Operations Command’s ... Thomas. During the presentation, General Thomas thanked Task Force Dagger Foundation for its ...
(Date:3/23/2017)... DC (PRWEB) , ... March 23, 2017 , ... News ... Dental Choice has helped score a major victory in Europe for public health and ... , Based on rigorous scientific research and the overwhelming support of European ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... an innovative patient - centric payment system, to expand its focus on patient ... the patient financial experience. , “At Ogden Clinic, we are working to ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 Under ... Chinese pharmaceutical packaging market size increased year by ... From 2017 to 2021, the market size will ... is expected to outnumber RMB140 billion in 2021, ... the rapid development of biological agents and supporting ...
(Date:3/22/2017)... Pennsylvania , 22. März 2017 /PRNewswire/ ... unabhängige und weltweit tätige Anbieter von Produkten ... heute den Erwerb von EPL Archives Inc. ... Stoffe, der Kunden im kompletten Zyklus regulierter ... Verwahrung von Proben, Speicherung von Dokumenten und ...
(Date:3/22/2017)... 22, 2017  Applied BioMath ( www.appliedbiomath.com ), ... research and development, today announced the latest line-up ... 2017 is a day full of presentations, posters, ... (QSP) community. The focus is to learn about ... accelerating drug research and development. The ...
Breaking Medicine Technology: